Smithfield Trust CO Gilead Sciences, Inc. Transaction History

Smithfield Trust CO

$2.04 Billion
Q3 2024

A detailed history of Smithfield Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 1,510 shares of GILD stock, worth $136,186. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,510

Previous 1,070 41.12%

Holding current value

$136,186

Previous $73,000 73.97%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $29,299 - $36,955	440 Added 41.12%	1,510 $127,000
Q2 2024 Jul 31, 2024	SELL	$63.15 - $72.88 $25,260 - $29,152	-400 Reduced 27.21%	1,070 $73,000
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $29,797 - $32,510	-403 Reduced 21.52%	1,470 $108,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $15,468 - $17,422	268 Added 16.7%	1,873 $115,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $7,819 - $9,798	135 Added 9.18%	1,605 $96,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $25,952 - $29,456	-400 Reduced 21.39%	1,470 $107,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $1,904 - $2,080	-30 Reduced 1.58%	1,870 $129,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $23,520 - $26,836	-392 Reduced 17.1%	1,900 $122,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $20,394 - $23,238	360 Added 18.63%	2,292 $134,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $15,959 - $20,066	-257 Reduced 11.74%	1,932 $122,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $86,808 - $100,800	1,200 Added 121.33%	2,189 $168,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $1,252 - $1,604	-20 Reduced 1.98%	989 $74,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $106,356 - $116,988	-1,726 Reduced 63.11%	1,009 $66,000
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $27,316 - $30,153	437 Added 19.02%	2,735 $173,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $15,467 - $17,345	250 Added 12.21%	2,298 $155,000
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $37,518 - $42,030	-600 Reduced 22.66%	2,048 $133,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $49,642 - $64,780	-820 Reduced 23.64%	2,648 $165,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $47,900 - $53,034	-672 Reduced 16.23%	3,468 $267,000
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $12,327 - $14,379	-190 Reduced 4.39%	4,140 $293,000
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $39,479 - $48,129	-542 Reduced 11.12%	4,330 $326,000
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $1,280 - $1,503	-18 Reduced 0.37%	4,872 $349,000
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $352,617 - $417,948	4,890	4,890 $397,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Gilead Sciences, Inc. Transaction History